cilengitide has been researched along with Neuroblastoma in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Horwacik, I; Rokita, H | 1 |
Bal-Mahieu, C; Baroncini, M; Dewitte, A; Lansiaux, A; Lartigau, E; Le Tinier, F; Leblond, P; Meignan, S; Sarrazin, T | 1 |
Cheresh, DA; Gillies, SD; Jonczyk, A; Lode, HN; Moehler, T; Reisfeld, RA; Xiang, R | 1 |
3 other study(ies) available for cilengitide and Neuroblastoma
Article | Year |
---|---|
Modulation of interactions of neuroblastoma cell lines with extracellular matrix proteins affects their sensitivity to treatment with the anti-GD2 ganglioside antibody 14G2a.
Topics: Adenosine Triphosphate; Animals; Antibodies, Monoclonal; Apoptosis; Bridged Bicyclo Compounds, Heterocyclic; Caspase 3; Cell Line, Tumor; Diterpenes; Extracellular Matrix Proteins; Gangliosides; Humans; Mice; Neuroblastoma; Small Molecule Libraries; Snake Venoms | 2017 |
Cilengitide targets pediatric glioma and neuroblastoma cells through cell detachment and anoikis induction.
Topics: Age Factors; Anoikis; Antineoplastic Agents; Cell Adhesion; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Flow Cytometry; Glioma; Humans; Integrin alphaVbeta3; Neoplasm Grading; Neuroblastoma; Radiotherapy, Adjuvant; Receptors, Vitronectin; Snake Venoms; Time Factors | 2013 |
Synergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastases.
Topics: Animals; Antigens, CD; Colonic Neoplasms; Humans; Immunotherapy; Immunotoxins; Integrin alphaV; Interleukin-2; Melanoma, Experimental; Mice; Neoplasm Metastasis; Neovascularization, Pathologic; Neuroblastoma; Peptides, Cyclic; Receptors, Vitronectin; Recombinant Fusion Proteins; Snake Venoms; Tumor Cells, Cultured | 1999 |